Oriola Oyj (0NES) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning everyone and a warm welcome to Aureola's full year results audio cast. I am Tua Stenius-Örnjön from Aureola's Investor Relations. With me today I have our CEO Katarina Gabrielsson and CFO Mats Danielsson. We have now moved to Audiocast, but the setup will be the same as before. After the presentation, we open up for your questions. And as a kind reminder, in the Q&A, we will first focus on questions relating to Oriola's business and financial performance. Like always, you can start posting questions to us already during the presentation through the chat. And finally, please note that we are recording this audio cast and the recording will be available on our website later today. And before handing over to Katariina, here is our customary disclaimer that we all should be aware of. And now, without further ado, Katariina, please go ahead. Thank you, Tuva. Also welcome on my behalf. The agenda is fairly as it normally is so we will start now to look at what the 2025 years highlights. During 2025 we delivered a steady progress and the second half was particularly strong and that of course is also good for the future. We can see that we have worked a lot with our customers during the year, and that has resulted in a higher customer satisfaction. While doing this, we have strengthened the partnerships. We are also onboarding new customers that we have already talked about during the 2025. And we have also worked more across the markets with our portfolios. And also worked more with the value-adding services, so not only moving products. And value-adding service is for example when we have excess stock, and that means that we are then having extra stock for our pharmaceutical companies in our warehouses, but get paid for that. We can see that we have a stronger...